| Literature DB >> 18481816 |
Eugene Braunwald1, Dominick Angiolillo, Eric Bates, Peter B Berger, Deepak Bhatt, Christopher P Cannon, Mark I Furman, Paul Gurbel, Alan D Michelson, Eric Peterson, Stephen Wiviott.
Abstract
In vitro platelet function tests are commonly applied in research and offer justification for using antiplatelet therapy. However, studies assessing the ability of standardized platelet function tests to predict patients' clinical response to aspirin or clopidogrel have generated contradictory results. At this time, there is no standardized definition for resistance to antiplatelet therapy, and the appropriate treatment of patients who are hyporesponsive to these agents is not known. Although such tests have a role in research, their place in guiding therapy remains to be established, and prospective trials are urgently needed. The ideal platelet function test for clinical practice would be rapid, easy-to-use, inexpensive, and reliable. Copyright (c) 2008 Wiley Periodicals, Inc.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18481816 PMCID: PMC6653601 DOI: 10.1002/clc.20361
Source DB: PubMed Journal: Clin Cardiol ISSN: 0160-9289 Impact factor: 2.882